Our projects use advanced genomics, cellular immunology, and transcriptomics to investigate the unique causes of immune diseases in individuals, aiming to identify new treatment targets and improve patient outcomes.

study how new therapeutics that treat malignancy impact on platelet function and contribute to dysregulation of thrombopoiesis and haemostasis.

The Whole Cell Model Development project, spearheaded by our ARC Centre of Excellence for the Mathematical Analysis of Cellular Systems (MACSYS), is dedicated to constructing mathematical and machine learning models of entire cells, known as Whole Cell Models (WCM).

The aim of this project is to replicate the protection induced by a live pathogen with a safe subunit construct.